Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant 5-FU and Cisplatin vs Surgery in Esophageal Adenocarcinoma
NCT00002883Phase 3Completed
- Sponsor
- Unicancer
- Start
- Oct 1996
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, fluorouracil in esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma, sponsored by Unicancer. Started Oct 1996; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00002883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002883.